important information about tecvayli  

• TECVAYLI may cause side effects that are serious, life-threatening or lead to death, including Cytokine Release Syndrome (CRS) and neurologic problems.¹
• Due to the risk of these symptoms, TECVAYLI is only available through the TECVAYLI and TALVEY Risk Evaluation and Mitigation Strategy (REMS).¹
  • You will be given a Patient Wallet Card from your healthcare provider that lists signs and symptoms of CRS and neurologic problems. Carry the Patient Wallet Card with you at all times and show it to all of your healthcare providers. You should call your healthcare provider right away if you develop any of the signs or symptoms of CRS and neurologic problems listed below at any time during your treatment:  
    • Cytokine Release Syndrome (CRS): fever (100.4°F or higher), difficulty breathing, chills, dizziness or lightheadedness, fast heartbeat, feeling anxious, confusion or restlessness, headache, increased liver enzymes in your blood
    • Neurologic problems: headache, jerking movements, rigid muscles, feeling restless, numbness and tingling (feeling like “pins and needles”), confusion, trouble speaking, muscle spasms, tremor, double vision, changes in your handwriting, problems walking, muscle weakness in your body or face, hearing loss, burning, throbbing, or stabbing pain

SUMMARY

See below for information from the TECVAYLI MEDICATION GUIDE, which may be helpful to address your question.

Please review the full TECVAYLI MEDICATION GUIDE for more information on “What is the most important information I should know about TECVAYLI” section.¹

How will I receive TECVAYLI¹?

• TECVAYLI will be given to you by your healthcare provider as an injection under your skin (subcutaneous injection), usually in your stomach-area (abdomen), your thigh or another area of your body may be injected.
• If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment. It is important for you to be monitored closely for side effects during treatment with TECVAYLI.

Before you receive TECVAYLI, tell your healthcare provider about all of your medical conditions, including if you¹:

• have an infection.
• are pregnant or plan to become pregnant. TECVAYLI may harm your unborn baby.
  • Your healthcare provider should do a pregnancy test before you start treatment with TECVAYLI.
  • You should use effective birth control (contraception) during treatment and for 5 months after your last dose of TECVAYLI.
  • Tell your healthcare provider right away if you become pregnant or think that you may be pregnant during treatment with TECVAYLI.
• are breastfeeding or plan to breastfeed. It is not known if TECVAYLI passes into your breast milk. Do not breastfeed during treatment and for 5 months after your last dose of TECVAYLI.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.¹

ADDITIONAL INFORMATION

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT MEDICATION GUIDE for TECVAYLI.¹